NBR2: A former junk gene emerges as a key player in tumor suppression.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

1. Decoding BRCA1 promoter hypermethylation: a new frontier in understanding sporadic breast cancer.Cancer gene therapy · 2025
   Article
2. Long Non-Coding, Micro, and Circular RNAs in Ovarian Cancer Metastasis: Pathways and Treatment Approaches.Reproductive sciences (Thousand Oaks, Calif.) · 2025
   Review
3. Nanopore adaptive sampling accurately detects nucleotide variants and improves the characterization of large-scale rearrangement for the diagnosis of cancer predisposition.Clinical and translational medicine · 2025
   Article
4. LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway.Genes & diseases · 2024
   Review
5. Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.PloS one · 2022
   Article
6. Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells.Cancers · 2021
   Article
7. Long Non-Coding RNA Neighbor of BRCA1 Gene 2: A Crucial Regulator in Cancer Biology.Frontiers in oncology · 2021
   Review
8. Complex Characterization of Germline Large Genomic Rearrangements of theInternational journal of molecular sciences · 2020
   Article
9. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.Theranostics · 2020
   Article
10. STIM2 interacts with AMPK and regulates calcium-induced AMPK activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
11. A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci.BMC cancer · 2018
    Article
12. Emerging roles of long non-coding RNAs in tumor metabolism.Journal of hematology & oncology · 2018
    Review
13. Long non-coding RNAs involved in autophagy regulation.Cell death & disease · 2017
    Review
14. Role of long non-coding RNAs in glucose metabolism in cancer.Molecular cancer · 2017
    Review
15. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.Cell cycle (Georgetown, Tex.) · 2016
    Article
16. Long non-coding RNAs in cancer metabolism.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
17. Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway.Technology in cancer research & treatment
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as